SMO ClinPlus CO.,LTD. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	819.09	803.73	760.04	586.23	502.97	335.29
Other Revenue	-	-	0	0	-	-
Revenue	819.09	803.73	760.04	586.23	502.97	335.29
Revenue Growth (YoY)	1.14%	5.75%	29.65%	16.55%	50.01%	10.46%
Cost of Revenue	612.92	607.75	528.94	426.25	371.77	237.64
Gross Profit	206.17	195.98	231.1	159.98	131.19	97.65
Selling, General & Admin	50.15	52.37	50.28	49.86	33.74	39.5
Research & Development	37.26	35.84	34.75	32.23	21.19	14.99
Other Operating Expenses	5.9	5.29	5.18	2.99	2.94	1.08
Operating Expenses	104.75	102.54	100.58	91.25	63.71	59.57
Operating Income	101.42	93.44	130.52	68.73	67.49	38.08
Interest Expense	-0.23	-0.44	-0.32	-0.18	-0.27	-
Interest & Investment Income	12.27	16.35	16.44	6.82	1.73	0.56
Earnings From Equity Investments	-	-	-	-	-	-1.75
Other Non Operating Income (Expenses)	-0.69	-0.77	-0.48	0.19	-0.52	-0.15
EBT Excluding Unusual Items	112.77	108.58	146.16	75.56	68.42	36.74
Gain (Loss) on Sale of Investments	0.17	0.58	1.14	0.84	-1.47	-
Gain (Loss) on Sale of Assets	-0.04	-0.12	0.02	0.02	-0.08	-0.05
Asset Writedown	-2.19	-	-0.01	-0	-0	-0
Other Unusual Items	25.92	12.54	13.72	4.41	-	4.83
Pretax Income	136.62	121.58	161.03	80.84	66.88	41.51
Income Tax Expense	15.08	15.15	26.3	8.43	9.11	6.19
Net Income	121.55	106.43	134.73	72.41	57.77	35.32
Net Income to Common	121.55	106.43	134.73	72.41	57.77	35.32
Net Income Growth	14.57%	-21.00%	86.06%	25.35%	63.58%	-32.55%
Shares Outstanding (Basic)	88	79	78	70	59	59
Shares Outstanding (Diluted)	88	79	79	71	59	59
Shares Change (YoY)	26.47%	0.06%	11.32%	20.98%	-	-
EPS (Basic)	1.38	1.35	1.72	1.04	0.99	0.60
EPS (Diluted)	1.38	1.35	1.71	1.02	0.98	0.60
EPS Growth	-9.41%	-21.05%	67.14%	3.91%	63.09%	-32.34%
Free Cash Flow	34.48	-10.29	104.6	32.48	37.11	18.36
Free Cash Flow Per Share	0.39	-0.13	1.33	0.46	0.63	0.31
Dividend Per Share	0.268	0.250	0.180	0.083	-	-
Dividend Growth	-3.49%	38.89%	116.61%	-	-	-
Gross Margin	25.17%	24.38%	30.41%	27.29%	26.08%	29.12%
Operating Margin	12.38%	11.63%	17.17%	11.72%	13.42%	11.36%
Profit Margin	14.84%	13.24%	17.73%	12.35%	11.49%	10.53%
Free Cash Flow Margin	4.21%	-1.28%	13.76%	5.54%	7.38%	5.48%
EBITDA	107.37	98.79	135.08	72.29	70.3	40.33
EBITDA Margin	13.11%	12.29%	17.77%	12.33%	13.98%	12.03%
D&A For EBITDA	5.95	5.35	4.55	3.56	2.81	2.25
EBIT	101.42	93.44	130.52	68.73	67.49	38.08
EBIT Margin	12.38%	11.63%	17.17%	11.72%	13.42%	11.36%
Effective Tax Rate	11.04%	12.46%	16.33%	10.42%	13.62%	14.92%
Revenue as Reported	819.09	803.73	760.04	586.23	502.97	335.29

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.